The expanding role of metformin: From COVID-19 outcomes to healthy aging management?
Keywords:
NoneAbstract
None
References
Petrelli F, Grappasonni I, Nguyen CTT, Tesauro M, Pantanetti P, Xhafa S, et al. Metformin and Covid-19: a systematic review of systematic reviews with meta-analysis. Acta Biomed. 2023 Aug 30;94(S3):e2023138. doi: 10.23750/abm.v94iS3.14405.
Gnesin F, Thuesen ACB, Kähler LKA, Madsbad S, Hemmingsen B. Metformin monotherapy for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020 Jun 5;6(6):CD012906. doi: 10.1002/14651858. CD012906.pub2.
Zhou T, Yu Y, Li L, Liu X, Xiang Q, Yu R. Bibliometric analysis of metformin as an immunomodulator (2013-2024). Front Immunol. 2025 Jan 8;15:1526481. doi: 10.3389/fimmu.2024.1526481.
Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H, MacDonald R, Hollenberg MD, Hill MA. Metformin: Is it a drug for all reasons and diseases? Metabolism. 2022 Aug;133:155223. doi: 10.1016/j.metabol.2022.155223.
Alshahrani O, Almalki MS. The Efficacy of Pharmacotherapy in the Treatment of Obesity in Patients With Type 2 Diabetes: A Systematic Review. Cureus. 2024 Jul 24;16(7):e65242. doi: 10.7759/cureus.65242.
Cangelosi G, Mancin S, Pantanetti P, Nguyen CTT, Morales Palomares S, Biondini F, et al. Lifestyle Medicine Case Manager Nurses for Type Two Diabetes Patients: An Overview of a Job Description Framework—A Narrative Review. Diabetology. 2024, 5, 375–388. doi.org/10.3390/diabetology5040029.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Giovanni Cangelosi, Fabio Petrelli

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.